Ignite Creation Date:
2024-05-06 @ 1:08 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03947437
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-13
First Post:
2019-05-09
Brief Title:
Phase 1b2a Trial to Evaluate LEP-F1 GLA-SE in Healthy Adults and Leprosy Patients
Sponsor:
Organization:
The Immunobiological Technology Institute Bio-Manguinhos Oswaldo Cruz Foundation Fiocruz
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
142
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: